These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 21724716)
1. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. Dalbeth N; McQueen FM; Singh JA; MacDonald PA; Edwards NL; Schumacher HR; Simon LS; Stamp LK; Neogi T; Gaffo AL; Khanna PP; Becker MA; Taylor WJ J Rheumatol; 2011 Jul; 38(7):1458-61. PubMed ID: 21724716 [TBL] [Abstract][Full Text] [Related]
2. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Dalbeth N; Schauer C; Macdonald P; Perez-Ruiz F; Schumacher HR; Hamburger S; Choi HK; McQueen FM; Doyle A; Taylor WJ Ann Rheum Dis; 2011 Apr; 70(4):597-604. PubMed ID: 21216814 [TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic measurement of tophi as an outcome measure for chronic gout. Perez-Ruiz F; Martin I; Canteli B J Rheumatol; 2007 Sep; 34(9):1888-93. PubMed ID: 17659752 [TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in chronic gout: a report from OMERACT 10. Singh JA; Taylor WJ; Simon LS; Khanna PP; Stamp LK; McQueen FM; Neogi T; Gaffo AL; Becker MA; MacDonald PA; Dabbous O; Strand V; Dalbeth ND; Aletaha D; Edwards NL; Schumacher HR J Rheumatol; 2011 Jul; 38(7):1452-7. PubMed ID: 21724715 [TBL] [Abstract][Full Text] [Related]
5. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. Taylor WJ; Redden D; Dalbeth N; Schumacher HR; Edwards NL; Simon LS; John MR; Essex MN; Watson DJ; Evans R; Rome K; Singh JA J Rheumatol; 2014 Mar; 41(3):574-80. PubMed ID: 24429178 [TBL] [Abstract][Full Text] [Related]
6. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase. Mandell BF; Yeo AE; Lipsky PE Arthritis Res Ther; 2018 Dec; 20(1):286. PubMed ID: 30594229 [TBL] [Abstract][Full Text] [Related]
7. OMERACT endorsement of measures of outcome for studies of acute gout. Singh JA; Taylor WJ; Dalbeth N; Simon LS; Sundy J; Grainger R; Alten R; March L; Strand V; Wells G; Khanna D; McQueen F; Schlesinger N; Boonen A; Boers M; Saag KG; Schumacher HR; Edwards NL J Rheumatol; 2014 Mar; 41(3):569-73. PubMed ID: 24334651 [TBL] [Abstract][Full Text] [Related]
8. Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group. Christiansen SN; Østergaard M; Slot O; Fana V; Terslev L Rheumatology (Oxford); 2021 Jan; 60(1):239-249. PubMed ID: 32696059 [TBL] [Abstract][Full Text] [Related]
9. Imaging as a potential outcome measure in gout studies: A systematic literature review. Durcan L; Grainger R; Keen HI; Taylor WJ; Dalbeth N Semin Arthritis Rheum; 2016 Apr; 45(5):570-9. PubMed ID: 26522139 [TBL] [Abstract][Full Text] [Related]
10. Ultrasound Evaluation of Three Outcome Domains in the Follow-up of Urate-Lowering Therapy in Gout: An Observational Study. Zhang W; Zhao D; Wu M; Chen W; Jin Z; Zhang H Ultrasound Med Biol; 2021 Jun; 47(6):1495-1505. PubMed ID: 33785225 [TBL] [Abstract][Full Text] [Related]
11. Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy. Christiansen SN; Østergaard M; Slot O; Keen H; Bruyn GAW; D'Agostino MA; Terslev L RMD Open; 2020 Jan; 6(1):. PubMed ID: 32396518 [TBL] [Abstract][Full Text] [Related]
12. Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trials. Taylor WJ; Singh JA; Saag KG; Dalbeth N; MacDonald PA; Edwards NL; Simon LS; Stamp LK; Neogi T; Gaffo AL; Khanna PP; Becker MA; Schumacher HR J Rheumatol; 2011 Jul; 38(7):1467-70. PubMed ID: 21724718 [TBL] [Abstract][Full Text] [Related]
13. The gouty tophus: a review. Chhana A; Dalbeth N Curr Rheumatol Rep; 2015 Mar; 17(3):19. PubMed ID: 25761926 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment. Peiteado D; Villalba A; Martín-Mola E; Balsa A; De Miguel E Clin Exp Rheumatol; 2017; 35(5):746-751. PubMed ID: 28281462 [TBL] [Abstract][Full Text] [Related]
15. Ultrasonography for diagnosing atypical gout. Two case reports. Le Goff B; Berthelot JM; André V; Guillot P; Maugars Y Joint Bone Spine; 2008 Oct; 75(5):610-2. PubMed ID: 18674948 [TBL] [Abstract][Full Text] [Related]
16. Imaging tools to measure treatment response in gout. Dalbeth N; Doyle AJ Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i27-i34. PubMed ID: 29272513 [TBL] [Abstract][Full Text] [Related]
17. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking. Modjinou DV; Krasnokutsky S; Gyftopoulos S; Pike VC; Karis E; Keenan RT; Lee K; Crittenden DB; Samuels J; Pillinger MH Clin Rheumatol; 2017 Sep; 36(9):2101-2107. PubMed ID: 28623421 [TBL] [Abstract][Full Text] [Related]
18. Retrospective longitudinal assessment of ultrasound gout lesions using the OMERACT semi-quantitative scoring system. Christiansen SN; Østergaard M; Slot O; Fana V; Terslev L Rheumatology (Oxford); 2022 Nov; 61(12):4711-4721. PubMed ID: 35298610 [TBL] [Abstract][Full Text] [Related]
19. Pus, pannus or tophus: coexistent rheumatoid arthritis and gout. Abdullah S; Scott K; Featherstone T; Coady D J Clin Rheumatol; 2010 Mar; 16(2):98. PubMed ID: 20216132 [No Abstract] [Full Text] [Related]
20. [Gouty tophus]. Inani K; Mernissi F Pan Afr Med J; 2014; 17():250. PubMed ID: 25309650 [No Abstract] [Full Text] [Related] [Next] [New Search]